Please login to the form below

Not currently logged in
Email:
Password:

Stada

This page shows the latest Stada news and features for those working in and with pharma, biotech and healthcare.

Takeda to sell Japan consumer health unit for $2.3bn

Takeda to sell Japan consumer health unit for $2.3bn

The Japanese pharma also entered an agreement with Stada last October to divest a portfolio of select OTC drugs for a total value of $660m. ... The Stada deal includes OTC vitamins and food supplements, and select products in the cardiovascular, diabetes,

Latest news

  • GlaxoSmithKline reportedly looking to sell select antibiotic brands GlaxoSmithKline reportedly looking to sell select antibiotic brands

    GSK also sold of its 15 consumer brands to German pharma company Stada Arzneimittel AG for over 300m around the same time. ... The Stada deal was just the latest in a string of divestments – in January GSK signed a deal worth up to 955m with Bavarian

  • Takeda divests over-the-counter and prescription drugs to Stada for $660m Takeda divests over-the-counter and prescription drugs to Stada for $660m

    Japanese drug-maker Takeda has entered an agreement with German pharma Stada to divest a portfolio of select over-the-counter (OTC) and prescription drugs for a total value of $660m. ... The portfolio of products to be divested to Stada and Acino brought

  • Post-merger Celgene to lead pharma growth Post-merger Celgene to lead pharma growth

    Behind Celgene is a cohort of five companies which are expected to post profit growth of 6-10%: AbbVie, AstraZeneca, Eli Lilly, Stada and Takeda.

  • Stada's €4.1bn takeover goes through Stada's €4.1bn takeover goes through

    German pharma company finally comes under new ownership. After months of wrangling, German pharma company Stada has finally come under new ownership after a successful tender by private equity firms Bain ... The buyout - which is the largest for a

  • Time running out on new Stada takeover bid Time running out on new Stada takeover bid

    Only 34% of shareholders have backed the deal so far. With a deadline looming on Wednesday, only a third of shareholders in German pharma company Stada have accepted the takeover bid ... As of Friday around 34% of Stada's shareholders had accepted, well

More from news
Approximately 10 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    The 2008 financial crash is a salutary reminder. Given this background what do we make of the deal where two private equity companies, Bain and Cinven, joined forces to acquire Stada ... So why did Bain/Cinven acquire Stada at a high price? Almost

  • Deal Watch February 2017 Deal Watch February 2017

    What is more than rumour, is the interest from several parties in acquiring the German generic company, Stada, which has pan-European capabilities and a foothold in Russia. ... Whatever happens to Stada this represents another chapter in the evolution of

  • Deal Watch table for August 2013 Deal Watch table for August 2013

    485. OptiMedica  /. Abbott. Acquisition. Ophthalmic device company. 400. Thornton &Ross /. Stada Arzneimittel. Acquisition. OTC manufacturer. 345. Endosense  /. St Jude Medical.

  • Pharma deals during August 2013 Pharma deals during August 2013

    In a defensive move the German drugmaker Stada Arzneimittel announced the $345m take-over of the UK OTC company, Thornton &Ross.Thornton &Ross is one of the fastest growing companies in ... the UK pharmaceutical market (11 per cent sales growth over the

  • Pharma deals during November 2012 Pharma deals during November 2012

    Veropharm, one of the largest generics companies in the fast-growing Russian market has, not surprisingly, been the subject of interest from companies such as GSK and Stada for some time.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Britannia promotes Robert Wood Britannia promotes Robert Wood

    Prior to joining Britannia, which is part of Stada, in early 2011, his roles included business unit director, pharmaceuticals at International SOS and vice president of business development at Optasia Medical.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...